Adam S. Bloom, Esq., is Counsel in Frier Levitt’s Regulatory Department. Adam’s practice focuses on counseling clients on issues relating to FDA regulatory, licensing, mergers and acquisitions, clinical trials and other client matters. He provides counsel to clients on matters relating the entire life cycle of products regulated by the FDA with an emphasis on regulatory compliance, commercial contracts, and advertising and promotional review.
Prior to joining Frier Levitt, Adam worked as corporate counsel at two pharmaceutical manufacturers.
The George Washington University Law School
Managing Editor – The George Washington International Law Review
University of Michigan
State of New York (pending)
State of Maryland
District of Columbia
U.S. District Court for the District of Columbia